EU Approval Of COVID-19 Vaccines Possible In Weeks
Executive Summary
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.
You may also be interested in...
COVID-19 Vaccine 'Brexit Bonus' A Myth
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
Experts Defend UK Agency Over Rapid Authorization Of COVID-19 Vaccine
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
Pfizer And Moderna Under Pressure To Offer Vaccine Supplies For Developing Nations
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.